???pagination.result.count???
???pagination.result.page???
1
A single-cell, time-resolved profiling of Xenopus mucociliary epithelium reveals nonhierarchical model of development. , Lee J ., Sci Adv. April 7, 2023; 9 (14): eadd5745.
Similarity in gene-regulatory networks suggests that cancer cells share characteristics of embryonic neural cells. , Zhang Z ., J Biol Chem. August 4, 2017; 292 (31): 12842-12859.
MiR-142-3p controls the specification of definitive hemangioblasts during ontogeny. , Nimmo R., Dev Cell. August 12, 2013; 26 (3): 237-49.
Signaling crosstalk between TGFβ and Dishevelled/ Par1b. , Mamidi A., Cell Death Differ. October 1, 2012; 19 (10): 1689-97.
TMEPAI, a transmembrane TGF-beta-inducible protein, sequesters Smad proteins from active participation in TGF-beta signaling. , Watanabe Y., Mol Cell. January 15, 2010; 37 (1): 123-34.
The evolutionally conserved activity of Dapper2 in antagonizing TGF-beta signaling. , Su Y., FASEB J. March 1, 2007; 21 (3): 682-90.
Inhibitor-resistant type I receptors reveal specific requirements for TGF-beta signaling in vivo. , Ho DM., Dev Biol. July 15, 2006; 295 (2): 730-42.
Emilin1 links TGF-beta maturation to blood pressure homeostasis. , Zacchigna L., Cell. March 10, 2006; 124 (5): 929-42.
Germ-layer specification and control of cell growth by Ectodermin, a Smad4 ubiquitin ligase. , Dupont S., Cell. April 8, 2005; 121 (1): 87-99.
The orphan receptor ALK7 and the Activin receptor ALK4 mediate signaling by Nodal proteins during vertebrate development. , Reissmann E., Genes Dev. August 1, 2001; 15 (15): 2010-22.
Ski represses bone morphogenic protein signaling in Xenopus and mammalian cells. , Wang W., Proc Natl Acad Sci U S A. December 19, 2000; 97 (26): 14394-9.
A Xenopus type I activin receptor mediates mesodermal but not neural specification during embryogenesis. , Chang C ., Development. February 1, 1997; 124 (4): 827-37.
A type 1 serine/threonine kinase receptor that can dorsalize mesoderm in Xenopus. , Mahony D., Proc Natl Acad Sci U S A. July 3, 1995; 92 (14): 6474-8.